GPR120 is a bona fide long-chain fatty acid sensor of the rhodopsin family and its agonists is suggested to hold promise as a therapeutic target for diabetes, metabolic disorders and inflammatory diseases [22]. This evidence concerns the gene FFAR4 and metabolic disease.